nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxymetazoline—NISCH—Paclitaxel—Docetaxel—pancreatic cancer	0.0319	1	CbGdCrCtD
Oxymetazoline—ADRA1A—Signaling Pathways—EGF—pancreatic cancer	5.87e-05	6.06e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—KRAS—pancreatic cancer	5.85e-05	6.04e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—GPCR downstream signaling—PIK3CA—pancreatic cancer	5.82e-05	6.01e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—PIK3CD—pancreatic cancer	5.8e-05	5.99e-05	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—SRC—pancreatic cancer	5.78e-05	5.97e-05	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—MMP9—pancreatic cancer	5.76e-05	5.95e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—KRAS—pancreatic cancer	5.75e-05	5.94e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—PIK3CA—pancreatic cancer	5.75e-05	5.94e-05	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—PTEN—pancreatic cancer	5.73e-05	5.92e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—GPCR downstream signaling—AKT1—pancreatic cancer	5.73e-05	5.92e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—NFKBIA—pancreatic cancer	5.7e-05	5.88e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—CASP3—pancreatic cancer	5.68e-05	5.86e-05	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—SRC—pancreatic cancer	5.66e-05	5.84e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—NOTCH1—pancreatic cancer	5.64e-05	5.83e-05	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—VEGFA—pancreatic cancer	5.63e-05	5.81e-05	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling by GPCR—AKT1—pancreatic cancer	5.59e-05	5.77e-05	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—STAT3—pancreatic cancer	5.57e-05	5.76e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—PIK3CB—pancreatic cancer	5.57e-05	5.75e-05	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—NRAS—pancreatic cancer	5.56e-05	5.74e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—CCND1—pancreatic cancer	5.52e-05	5.71e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—EGFR—pancreatic cancer	5.52e-05	5.71e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—PIK3CA—pancreatic cancer	5.52e-05	5.7e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—PIK3CG—pancreatic cancer	5.52e-05	5.7e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—NRAS—pancreatic cancer	5.52e-05	5.7e-05	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—VEGFA—pancreatic cancer	5.51e-05	5.69e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—CTNNB1—pancreatic cancer	5.47e-05	5.65e-05	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—STAT3—pancreatic cancer	5.46e-05	5.64e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—EGF—pancreatic cancer	5.45e-05	5.63e-05	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—NRAS—pancreatic cancer	5.44e-05	5.62e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—EGFR—pancreatic cancer	5.41e-05	5.59e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Metabolism—PTEN—pancreatic cancer	5.38e-05	5.56e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—PIK3CA—pancreatic cancer	5.37e-05	5.55e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—MMP9—pancreatic cancer	5.36e-05	5.54e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—CXCL8—pancreatic cancer	5.35e-05	5.53e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—PIK3CB—pancreatic cancer	5.35e-05	5.53e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—PTEN—pancreatic cancer	5.33e-05	5.51e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—PIK3CD—pancreatic cancer	5.33e-05	5.51e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—HRAS—pancreatic cancer	5.32e-05	5.49e-05	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—SRC—pancreatic cancer	5.31e-05	5.49e-05	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—AKT1—pancreatic cancer	5.3e-05	5.47e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—PIK3CA—pancreatic cancer	5.29e-05	5.46e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCR downstream signaling—PIK3CA—pancreatic cancer	5.28e-05	5.45e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—PIK3CD—pancreatic cancer	5.22e-05	5.39e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—KRAS—pancreatic cancer	5.22e-05	5.39e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—PIK3CB—pancreatic cancer	5.2e-05	5.38e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling by GPCR—AKT1—pancreatic cancer	5.2e-05	5.37e-05	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—MYC—pancreatic cancer	5.18e-05	5.35e-05	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—VEGFA—pancreatic cancer	5.18e-05	5.35e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—GPCR downstream signaling—AKT1—pancreatic cancer	5.17e-05	5.34e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR downstream signaling—PIK3CA—pancreatic cancer	5.17e-05	5.34e-05	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—TGFB1—pancreatic cancer	5.17e-05	5.34e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—CXCL8—pancreatic cancer	5.14e-05	5.31e-05	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—STAT3—pancreatic cancer	5.13e-05	5.29e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—CASP3—pancreatic cancer	5.12e-05	5.29e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—PIK3CB—pancreatic cancer	5.12e-05	5.29e-05	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—NRAS—pancreatic cancer	5.11e-05	5.28e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—KRAS—pancreatic cancer	5.11e-05	5.28e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—HRAS—pancreatic cancer	5.11e-05	5.28e-05	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—MYC—pancreatic cancer	5.07e-05	5.24e-05	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—EGFR—pancreatic cancer	5.06e-05	5.23e-05	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—TGFB1—pancreatic cancer	5.06e-05	5.22e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—PIK3CB—pancreatic cancer	5.06e-05	5.22e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—EGFR—pancreatic cancer	5.03e-05	5.19e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—PTGS2—pancreatic cancer	5.01e-05	5.17e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—CXCL8—pancreatic cancer	5e-05	5.17e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—CCND1—pancreatic cancer	4.99e-05	5.15e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—HRAS—pancreatic cancer	4.97e-05	5.13e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—GPCR downstream signaling—AKT1—pancreatic cancer	4.97e-05	5.13e-05	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—EGFR—pancreatic cancer	4.96e-05	5.12e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—SRC—pancreatic cancer	4.95e-05	5.11e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—CTNNB1—pancreatic cancer	4.94e-05	5.1e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—CXCL8—pancreatic cancer	4.92e-05	5.08e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—CASP3—pancreatic cancer	4.92e-05	5.08e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—HRAS—pancreatic cancer	4.89e-05	5.05e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—PIK3CD—pancreatic cancer	4.85e-05	5.01e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—MMP9—pancreatic cancer	4.84e-05	5e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—GPCR downstream signaling—AKT1—pancreatic cancer	4.83e-05	4.99e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—VEGFA—pancreatic cancer	4.82e-05	4.98e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—PTEN—pancreatic cancer	4.81e-05	4.97e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR downstream signaling—PIK3CA—pancreatic cancer	4.8e-05	4.96e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—PIK3CA—pancreatic cancer	4.79e-05	4.95e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—CCND1—pancreatic cancer	4.79e-05	4.95e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—CASP3—pancreatic cancer	4.79e-05	4.94e-05	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—KRAS—pancreatic cancer	4.78e-05	4.94e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—STAT3—pancreatic cancer	4.77e-05	4.93e-05	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—MYC—pancreatic cancer	4.76e-05	4.92e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—NRAS—pancreatic cancer	4.76e-05	4.91e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—GPCR downstream signaling—AKT1—pancreatic cancer	4.75e-05	4.91e-05	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—TGFB1—pancreatic cancer	4.75e-05	4.91e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—KRAS—pancreatic cancer	4.75e-05	4.9e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—CTNNB1—pancreatic cancer	4.74e-05	4.9e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—CASP3—pancreatic cancer	4.71e-05	4.87e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—AKT1—pancreatic cancer	4.7e-05	4.85e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—PIK3CA—pancreatic cancer	4.69e-05	4.85e-05	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—KRAS—pancreatic cancer	4.68e-05	4.84e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—CCND1—pancreatic cancer	4.66e-05	4.81e-05	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—EGFR—pancreatic cancer	4.66e-05	4.81e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—MMP9—pancreatic cancer	4.65e-05	4.8e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—PIK3CB—pancreatic cancer	4.65e-05	4.8e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—PTEN—pancreatic cancer	4.62e-05	4.78e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—CTNNB1—pancreatic cancer	4.61e-05	4.77e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—CCND1—pancreatic cancer	4.59e-05	4.74e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—PIK3CB—pancreatic cancer	4.55e-05	4.7e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—CTNNB1—pancreatic cancer	4.54e-05	4.69e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—MMP9—pancreatic cancer	4.52e-05	4.67e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—AKT1—pancreatic cancer	4.51e-05	4.66e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—PTEN—pancreatic cancer	4.5e-05	4.65e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—CXCL8—pancreatic cancer	4.46e-05	4.61e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—SRC—pancreatic cancer	4.46e-05	4.61e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—MMP9—pancreatic cancer	4.45e-05	4.6e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—HRAS—pancreatic cancer	4.44e-05	4.58e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—MYC—pancreatic cancer	4.43e-05	4.58e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—PTEN—pancreatic cancer	4.43e-05	4.57e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—TGFB1—pancreatic cancer	4.42e-05	4.57e-05	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—KRAS—pancreatic cancer	4.4e-05	4.55e-05	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—PIK3CA—pancreatic cancer	4.4e-05	4.54e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—AKT1—pancreatic cancer	4.39e-05	4.53e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—CXCL8—pancreatic cancer	4.37e-05	4.52e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—PTEN—pancreatic cancer	4.37e-05	4.51e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—PIK3CA—pancreatic cancer	4.36e-05	4.51e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—VEGFA—pancreatic cancer	4.35e-05	4.49e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—HRAS—pancreatic cancer	4.34e-05	4.49e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—EGFR—pancreatic cancer	4.33e-05	4.48e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—AKT1—pancreatic cancer	4.32e-05	4.46e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCR downstream signaling—AKT1—pancreatic cancer	4.31e-05	4.46e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—STAT3—pancreatic cancer	4.31e-05	4.45e-05	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—PIK3CA—pancreatic cancer	4.3e-05	4.45e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—NRAS—pancreatic cancer	4.3e-05	4.44e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—SRC—pancreatic cancer	4.29e-05	4.43e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—CASP3—pancreatic cancer	4.27e-05	4.41e-05	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—TP53—pancreatic cancer	4.25e-05	4.39e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—PIK3CB—pancreatic cancer	4.23e-05	4.37e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR downstream signaling—AKT1—pancreatic cancer	4.22e-05	4.36e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—CASP3—pancreatic cancer	4.18e-05	4.32e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—VEGFA—pancreatic cancer	4.18e-05	4.31e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—SRC—pancreatic cancer	4.17e-05	4.31e-05	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—TP53—pancreatic cancer	4.16e-05	4.3e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—CCND1—pancreatic cancer	4.16e-05	4.3e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—STAT3—pancreatic cancer	4.13e-05	4.27e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—NRAS—pancreatic cancer	4.12e-05	4.26e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—CTNNB1—pancreatic cancer	4.12e-05	4.25e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—SRC—pancreatic cancer	4.1e-05	4.24e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—KRAS—pancreatic cancer	4.09e-05	4.23e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—CCND1—pancreatic cancer	4.07e-05	4.21e-05	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—HRAS—pancreatic cancer	4.07e-05	4.2e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—CXCL8—pancreatic cancer	4.06e-05	4.2e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—VEGFA—pancreatic cancer	4.06e-05	4.2e-05	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—PIK3CA—pancreatic cancer	4.04e-05	4.18e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—MMP9—pancreatic cancer	4.04e-05	4.17e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—HRAS—pancreatic cancer	4.04e-05	4.17e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—CTNNB1—pancreatic cancer	4.03e-05	4.17e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—STAT3—pancreatic cancer	4.02e-05	4.15e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—PTEN—pancreatic cancer	4.01e-05	4.15e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—NRAS—pancreatic cancer	4.01e-05	4.14e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—MYC—pancreatic cancer	4e-05	4.13e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—VEGFA—pancreatic cancer	4e-05	4.13e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—TGFB1—pancreatic cancer	3.99e-05	4.12e-05	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—HRAS—pancreatic cancer	3.98e-05	4.11e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—STAT3—pancreatic cancer	3.96e-05	4.09e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—MMP9—pancreatic cancer	3.95e-05	4.08e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—NRAS—pancreatic cancer	3.95e-05	4.08e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—PTEN—pancreatic cancer	3.93e-05	4.06e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR downstream signaling—AKT1—pancreatic cancer	3.92e-05	4.05e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—AKT1—pancreatic cancer	3.92e-05	4.05e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—EGFR—pancreatic cancer	3.91e-05	4.04e-05	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—TP53—pancreatic cancer	3.91e-05	4.04e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—CASP3—pancreatic cancer	3.89e-05	4.02e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—MYC—pancreatic cancer	3.84e-05	3.97e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—AKT1—pancreatic cancer	3.84e-05	3.96e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—TGFB1—pancreatic cancer	3.83e-05	3.96e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Metabolism—PIK3CA—pancreatic cancer	3.79e-05	3.92e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—CCND1—pancreatic cancer	3.78e-05	3.91e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—PIK3CA—pancreatic cancer	3.76e-05	3.89e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—EGFR—pancreatic cancer	3.76e-05	3.88e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—CTNNB1—pancreatic cancer	3.75e-05	3.87e-05	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—HRAS—pancreatic cancer	3.74e-05	3.86e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—MYC—pancreatic cancer	3.74e-05	3.86e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—TGFB1—pancreatic cancer	3.73e-05	3.85e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—SRC—pancreatic cancer	3.72e-05	3.85e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—KRAS—pancreatic cancer	3.7e-05	3.82e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—MYC—pancreatic cancer	3.68e-05	3.8e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—MMP9—pancreatic cancer	3.67e-05	3.8e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—TGFB1—pancreatic cancer	3.67e-05	3.79e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—EGFR—pancreatic cancer	3.66e-05	3.78e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—PTEN—pancreatic cancer	3.65e-05	3.77e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—SRC—pancreatic cancer	3.65e-05	3.77e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—TP53—pancreatic cancer	3.64e-05	3.76e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—VEGFA—pancreatic cancer	3.63e-05	3.75e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—EGFR—pancreatic cancer	3.6e-05	3.72e-05	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—AKT1—pancreatic cancer	3.59e-05	3.71e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—STAT3—pancreatic cancer	3.59e-05	3.71e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—NRAS—pancreatic cancer	3.58e-05	3.7e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—AKT1—pancreatic cancer	3.56e-05	3.68e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—VEGFA—pancreatic cancer	3.55e-05	3.67e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—KRAS—pancreatic cancer	3.55e-05	3.67e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—STAT3—pancreatic cancer	3.52e-05	3.63e-05	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—AKT1—pancreatic cancer	3.52e-05	3.63e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—NRAS—pancreatic cancer	3.51e-05	3.62e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—HRAS—pancreatic cancer	3.48e-05	3.6e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—KRAS—pancreatic cancer	3.45e-05	3.57e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—KRAS—pancreatic cancer	3.4e-05	3.51e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—PIK3CA—pancreatic cancer	3.4e-05	3.51e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—SRC—pancreatic cancer	3.39e-05	3.5e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—MYC—pancreatic cancer	3.34e-05	3.45e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—TGFB1—pancreatic cancer	3.33e-05	3.44e-05	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—AKT1—pancreatic cancer	3.3e-05	3.41e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—VEGFA—pancreatic cancer	3.3e-05	3.41e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—TP53—pancreatic cancer	3.29e-05	3.39e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—MYC—pancreatic cancer	3.27e-05	3.37e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—STAT3—pancreatic cancer	3.27e-05	3.37e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—EGFR—pancreatic cancer	3.26e-05	3.37e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—PIK3CA—pancreatic cancer	3.26e-05	3.37e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—TGFB1—pancreatic cancer	3.26e-05	3.37e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—NRAS—pancreatic cancer	3.26e-05	3.37e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—EGFR—pancreatic cancer	3.2e-05	3.3e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—PIK3CA—pancreatic cancer	3.17e-05	3.28e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—TP53—pancreatic cancer	3.16e-05	3.26e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—HRAS—pancreatic cancer	3.14e-05	3.25e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—PIK3CA—pancreatic cancer	3.12e-05	3.23e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Metabolism—AKT1—pancreatic cancer	3.1e-05	3.2e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—KRAS—pancreatic cancer	3.08e-05	3.18e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—PIK3CA—pancreatic cancer	3.08e-05	3.18e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—AKT1—pancreatic cancer	3.07e-05	3.17e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—TP53—pancreatic cancer	3.07e-05	3.17e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—MYC—pancreatic cancer	3.04e-05	3.14e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—TGFB1—pancreatic cancer	3.03e-05	3.13e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—TP53—pancreatic cancer	3.02e-05	3.12e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—KRAS—pancreatic cancer	3.02e-05	3.12e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—HRAS—pancreatic cancer	3.02e-05	3.12e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—EGFR—pancreatic cancer	2.97e-05	3.07e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—HRAS—pancreatic cancer	2.94e-05	3.03e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—HRAS—pancreatic cancer	2.89e-05	2.98e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—PIK3CA—pancreatic cancer	2.83e-05	2.93e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—KRAS—pancreatic cancer	2.8e-05	2.9e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—AKT1—pancreatic cancer	2.77e-05	2.87e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—PIK3CA—pancreatic cancer	2.77e-05	2.86e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—TP53—pancreatic cancer	2.74e-05	2.83e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—TP53—pancreatic cancer	2.68e-05	2.77e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—AKT1—pancreatic cancer	2.66e-05	2.75e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—HRAS—pancreatic cancer	2.62e-05	2.71e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—AKT1—pancreatic cancer	2.59e-05	2.68e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—PIK3CA—pancreatic cancer	2.58e-05	2.66e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—HRAS—pancreatic cancer	2.57e-05	2.65e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—AKT1—pancreatic cancer	2.55e-05	2.63e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—AKT1—pancreatic cancer	2.52e-05	2.6e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—TP53—pancreatic cancer	2.49e-05	2.57e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—HRAS—pancreatic cancer	2.38e-05	2.46e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—AKT1—pancreatic cancer	2.31e-05	2.39e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—AKT1—pancreatic cancer	2.27e-05	2.34e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—AKT1—pancreatic cancer	2.11e-05	2.17e-05	CbGpPWpGaD
